Every earnings call for HIKAL — management tone, guidance, KPIs and promise tracking, quarter by quarter.
HIKAL · 7 transcripts · Healthcare · latest Q4 FY26Hikal Limited has 7 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
FY26 Revenue ₹1,713 cr; FY26 EBITDA Margin 12.9%; FY26 PBT ₹-79 cr. Q4 FY26 revenue at INR 519 crores, with EBITDA margins improving to 20.3%.
Read full transcript & analysisConsolidated Revenue ₹494 cr; Consolidated EBITDA ₹83 cr; Consolidated EBITDA Margin 16.8%. Consolidated revenue for Q3 FY26 stood at INR494 crores.
Read full transcript & analysisConsolidated Revenue ₹319 cr; Consolidated EBITDA ₹8 cr; Consolidated EBITDA Margin 2.6%. Consolidated Revenue for Q2 FY26 stood at ₹319 crores.
Read full transcript & analysisRevenue ₹380 cr (−7% YoY); EBITDA ₹25 cr; EBITDA Margin 6.5% (−55% YoY). Consolidated Revenue for Q1 FY26 stood at ₹380 crores, a 6.6% decline YoY from ₹407 crores in Q1 FY25.
Read full transcript & analysisFY25 Revenue ₹1,860 cr; FY25 EBITDA ₹328 cr; FY25 EBITDA Margin 17.7%. Q4 FY25 Revenue amounted to ₹552 crores.
Read full transcript & analysisRevenue ₹448 cr; EBITDA ₹72 cr (+11% YoY). Q3 FY25 Revenue: INR448 crores.
Read full transcript & analysisRevenue ₹453 cr (+29% YoY); EBITDA ₹75 cr (+30% YoY); EBITDA Margin 16.5%. Q2 FY25 Revenue stood at INR 453 crores, representing a 29% growth YoY and QoQ.
Read full transcript & analysis